Company / AR per Share
Insight Molecular Diagnostics Inc. AR per Share History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest AR per Share
$0.06
FY2025
5-year range
$0.02 / $0.20
FY2021-FY2025
Trend
-66.9%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Declined from $0.08 to $0.06 over the past 2 years.
Based on SEC 10-K filings.
0.06 in FY2025 with a 5-year CAGR of +78.6%.
Declined from $0.08 to $0.06 over the past 2 years.
AR per Share over time
Growth rates
- 3-Year CAGR
- +43.6%
- 5-Year CAGR
- +78.6%
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, ar per share decreased 66.9% year-over-year.
- Peak ar per share was recorded in FY2024.
- Lowest ar per share in the period was in FY2020.
Company context
Key Data Points
- Altman Z-Score -7.34 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | AR per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.06 | -66.9% |
| FY2024 | $0.20 | +139.3% |
| FY2023 | $0.08 | +274.0% |
| FY2022 | $0.02 | +4.9% |
| FY2021 | $0.02 | +484.1% |
| FY2020 | $0.00 | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026